219694-63-0O=C(O)CCCC(=O)NCCc1cnc[nH]1KZIMLUFVKJLCCH-UHFFFAOYSA-NIngavirin has been used in trials studying the treatment of Influenza and Common Cold.
219694-63-0DTXSID90433141CHEMBL4297291Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Danger
H302 (33.3%): Harmful if swallowed [Warning Acute toxicity, oral]
P233, P260, P261, P264, P264+P265, P270, P271, P272, P280, P284, P301+P317, P302+P352, P304+P340, P305+P351+P338, P321, P330, P332+P317, P333+P317, P337+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 3 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
J - Antiinfectives for systemic use
QJ - Antiinfectives for systemic use
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…